BALAXI PHARMACEUTICALS
|
BALAXI PHARMACEUTICALS Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹29 Cr | ₹2.02 Cr | ₹57 Cr | ₹55 Cr | ₹44 Cr |
| Adjustment | ₹7.43 Cr | ₹-1.14 Cr | ₹8.03 Cr | ₹1.18 Cr | ₹-0.59 Cr |
| Changes In working Capital | ₹-68 Cr | ₹11 Cr | ₹-47 Cr | ₹-16 Cr | ₹-41 Cr |
| Cash Flow after changes in Working Capital | ₹-32 Cr | ₹12 Cr | ₹18 Cr | ₹40 Cr | ₹2.60 Cr |
| Cash Flow from Operating Activities | ₹-35 Cr | ₹4.87 Cr | ₹6.08 Cr | ₹34 Cr | ₹0.00 Cr |
| Cash Flow from Investing Activities | ₹-22 Cr | ₹-1.05 Cr | ₹-11 Cr | ₹-28 Cr | ₹-5.97 Cr |
| Cash Flow from Financing Activities | ₹34 Cr | ₹30 Cr | ₹26 Cr | ₹-0.16 Cr | ₹3.65 Cr |
| Net Cash Inflow / Outflow | ₹-23 Cr | ₹34 Cr | ₹21 Cr | ₹5.53 Cr | ₹-2.32 Cr |
| Opening Cash & Cash Equivalents | ₹62 Cr | ₹28 Cr | ₹7.19 Cr | ₹1.66 Cr | ₹3.98 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
| Closing Cash & Cash Equivalent | ₹39 Cr | ₹62 Cr | ₹28 Cr | ₹7.19 Cr | ₹1.66 Cr |
Compare Cashflow Statement of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹236.9 Cr | 4.4% | -4.3% | -54.5% | Stock Analytics | |
| ADANI ENTERPRISES | ₹288,990.0 Cr | -1.8% | -6.4% | -13.3% | Stock Analytics | |
| REDINGTON | ₹20,642.8 Cr | -1.9% | -7.4% | 52.1% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹10,414.1 Cr | -0.8% | 2.5% | 47.1% | Stock Analytics | |
| MMTC | ₹10,110.0 Cr | -1% | -3.9% | -14.9% | Stock Analytics | |
| HONASA CONSUMER | ₹8,994.9 Cr | -1.1% | -8.2% | -34.4% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | 4.4% |
-4.3% |
-54.5% |
| SENSEX | 0.9% |
2.5% |
3.7% |
You may also like the below Video Courses